healthtech

Healthcare AI startup Qritive raises $7.5 million in funding round led by MassMutual

• ByStartupStory     |    January 10, 2023

Qritive, a healthcare AI firm, has announced a $7.5 million investment round headed by MassMutual. The round was also attended by SEEDS Capital and Exfinty Venture Partners. According to a release, the firm would use this new funding to drive global expansion, increase its product offering, and assist regulatory clearances. Qritive, founded in 2017 by Dr Aneesh Sathe and Dr Kaveh Taghipour, provides fast and accurate pathology interpretations for cancer detection, strengthening imaging accuracy, and improving health outcomes with the help of AI-based solutions. Qritive is headquartered in Singapore, with US operations in San Diego and India operations in Pune. The company now has a presence in Singapore, the United States, and India.

Aneesh Sathe, CEO of Qritive in a statement said, “Complexity of diagnostics has increased considerably and having tools that increase accuracy and throughput really fast has become instrumental for clinicians worldwide.”

The prevalence of the rise in cancer incidence around the world, with Asia accounting for half of all cancer cases by 2030, was noticed by Chinnu Senthilkumar, Managing Partner of Exfinity Venture Partners. He added that the clinical-grade AI-powered solution from Qritive will alter diagnosis by being disruptive, accurate, and reducing the existing bottlenecks. “Speed and accuracy are of the utmost importance, especially in the backdrop of a severe pathologist shortage,” he stated.

Ryan Collins, Managing Director at MassMutual Ventures said, “Qritive’s platform digitizes and streamlines the pathology workflow from end-to-end, supporting clinicians with a wide range of tools – including image analysis, case management, and reporting modules. With an international network of pathologists, Qritive is uniquely positioned to accelerate the adoption of digital pathology across the globe.”

Follow Startup Story